Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20341 AL 20355

LRRK2 and Parkinson's disease: from genetics to targeted therapy

Sosero YL, Gan-Or Z.

Ann Clin Transl Neurol. 2023 Jun;10(6):850-864. doi: 10.1002/acn3.51776. Epub 2023 Apr 6.

Mixed pathology as a rule, not exception: Time to reconsider disease nosology

Chu Y, Hirst WD, Kordower JH.

Handb Clin Neurol. 2023;192:57-71. doi: 10.1016/B978-0-323-85538-9.00012-2.

Nanoparticle Mediated Gene Therapy: A Trailblazer Armament to Fight CNS Disorders

Annu, Rehman S, Nabi B, Sartaj A, Md S, Sahoo PK, Baboota S, Ali J.

Curr Med Chem. 2023;30(3):304-315. doi: 10.2174/0929867329666220105122318.

Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions

Koerich S, Parreira GM, de Almeida DL, Vieira RP, de Oliveira ACP.

Curr Neuropharmacol. 2023;21(2):219-234. doi: 10.2174/1570159X20666220922153903.

Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders

Domínguez-Fernández C, Egiguren-Ortiz J, Razquin J, Gómez-Galán M, De Las Heras-García L, Paredes-Rodríguez E, Astigarraga E, Miguélez C, Barreda-Gómez G.

Int J Mol Sci. 2023 Feb 7;24(4):3321. doi: 10.3390/ijms24043321.

The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases

Rezaee D, Saadatpour F, Akbari N, Zoghi A, Najafi S, Beyranvand P, Zamani-Rarani F, Rashidi MA, Bagheri-Mohammadi S, Bakhtiari M.

Ageing Res Rev. 2023 Dec;92:102090. doi: 10.1016/j.arr.2023.102090. Epub 2023 Oct 11.

The Vitamin D Receptor as a Potential Target for the Treatment of Age-Related Neurodegenerative Diseases Such as Alzheimer's and Parkinson's Diseases: A Narrative Review

Lasoń W, Jantas D, Leśkiewicz M, Regulska M, Basta-Kaim A.

Cells. 2023 Feb 19;12(4):660. doi: 10.3390/cells12040660.

Fundamental neurochemistry review: Old brain stories - Influence of age and sex on the neurodegeneration-associated lipid changes

Cuenca-Bermejo L, Prinetti A, Kublickiene K, Raparelli V, Kautzky-Willer A, Norris CM, Pilote L; GOING-FWD Consortium; Herrero MT.

J Neurochem. 2023 Aug;166(3):427-452. doi: 10.1111/jnc.15834. Epub 2023 Jun 20.

Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease

Nowell J, Blunt E, Gupta D, Edison P.

Ageing Res Rev. 2023 Aug;89:101979. doi: 10.1016/j.arr.2023.101979. Epub 2023 Jun 14.

Cognitive-motor dual-task interference in Alzheimer's disease, Parkinson's disease, and prodromal neurodegeneration: A scoping review

Longhurst JK, Rider JV, Cummings JL, John SE, Poston B, Landers MR.

Gait Posture. 2023 Sep;105:58-74. doi: 10.1016/j.gaitpost.2023.07.277. Epub 2023 Jul 17.

Natural Products as Bioactive Agents in the Prevention of Dementia

Ullah H, Hussain A, Asif M, Nawaz F, Rasool M.

CNS Neurol Disord Drug Targets. 2023;22(4):466-476. doi: 10.2174/1871527321666220422085835.

Disease-modifying vs symptomatic treatments: Splitting over lumping

Duque KR, Vizcarra JA, Hill EJ, Espay AJ.

Handb Clin Neurol. 2023;193:187-209. doi: 10.1016/B978-0-323-85555-6.00020-5.

Small molecule-based fluorescent probes for the detection of α-Synuclein aggregation states

Haque R, Maity D.

Bioorg Med Chem Lett. 2023 Apr 15;86:129257. doi: 10.1016/j.bmcl.2023.129257. Epub 2023 Mar 24.

Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases

Lo CH, Zeng J.

Transl Neurodegener. 2023 Jun 8;12(1):29. doi: 10.1186/s40035-023-00362-0.

Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging

Martínez-Coria H, Arrieta-Cruz I, Gutiérrez-Juárez R, López-Valdés HE.

Int J Mol Sci. 2023 Feb 21;24(5):4297. doi: 10.3390/ijms24054297.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias